Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier

There is an urgent and unmet need to develop effective therapies for triple negative breast cancers (TNBCs) which are much more aggressive and have poor prognosis due to lack of receptor targets for Her2-targeted and endocrine therapy. In this study we systematically evaluated the effect of Vorinost...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Weina, Sun, Jingjing, Xu, Jieni, Luo, Zhangyi, Diao, Dingwei, Zhang, Ziqian, Oberly, Patrick J., Minnigh, Margaret Beth, Xie, Wen, Poloyac, Samuel M, Huang, Yi, Li, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052901/
https://www.ncbi.nlm.nih.gov/pubmed/32194813
http://dx.doi.org/10.7150/thno.38973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052901/
https://www.ncbi.nlm.nih.gov/pubmed/32194813
http://dx.doi.org/10.7150/thno.38973

Ejemplares similares